World's Best Scientists 2026 revealed!
Georgia D. Tomaras

Georgia D. Tomaras

D-Index & Metrics

Immunology

D-Index
91
Citations
32352
World Ranking
1033
National Ranking
559

Medicine

D-Index
91
Citations
32352
World Ranking
11709
National Ranking
6006

Research.com Recognitions

  • 2018 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Georgia D. Tomaras is affiliated with Duke University in the United States. Their research primarily focuses on immunology and microbiology, with a strong emphasis on virology, infectious diseases, and molecular biology. The scholar's work is concentrated around HIV research and treatment, monoclonal and polyclonal antibodies, and vaccine development using immunoinformatics approaches. They also study immune cell function, immunotherapy, and T-cell and B-cell immunology.

Key recent publications authored or co-authored by Georgia D. Tomaras include:

  • Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study, 2021, Science
  • Vaccination induces HIV broadly neutralizing antibody precursors in humans, 2022, Science
  • 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates, 2020, Science Immunology
  • Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial, 2022, Nature Medicine
  • Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition, 2022, Nature Medicine

Frequently collaborating co-authors include:

  • David C. Montefiori
  • Kelly E. Seaton
  • Guido Ferrari
  • Lawrence Corey
  • M. Juliana McElrath

Georgia D. Tomaras has contributed extensively to several publication venues, notably:

  • UNC Libraries
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • PLoS Pathogens
  • npj Vaccines

Their research covers a broad spectrum of topics including:

  • HIV Research and Treatment
  • Monoclonal and Polyclonal Antibodies Research
  • HIV/AIDS drug development and treatment
  • Vaccines and immunoinformatics approaches
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology

In 2018, Georgia D. Tomaras was recognized as a Fellow of the American Association for the Advancement of Science (AAAS).

Best Publications

  • Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

    Brandon F. Keele;Elena E. Giorgi;Elena E. Giorgi;Jesus F. Salazar-Gonzalez;Julie M. Decker

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner

  • The immune response during acute HIV-1 infection: clues for vaccine development.

    Andrew J. McMichael;Persephone Borrow;Georgia D. Tomaras;Nilu Goonetilleke

  • Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

    Georgia D. Tomaras;Nicole L. Yates;Pinghuang Liu;Li Qin

  • Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

    Scott M. Hammer;Magdalena E. Sobieszczyk;Holly Janes;Shelly T. Karuna

  • Combination therapy with anti-HIV-1 antibodies maintains viral suppression

    Pilar Mendoza;Henning Gruell;Lilian Nogueira;Joy A. Pai

  • Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors

    Mattia Bonsignori;Kwan Ki Hwang;Xi Chen;Chun Yen Tsao

  • Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

    Nicole L. Yates;Nicole L. Yates;Hua Xin Liao;Hua Xin Liao;Youyi Fong;Allan DeCamp

  • Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

    Mattia Bonsignori;Justin Pollara;M. Anthony Moody;Michael D. Alpert

  • Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

    Georgia D. Tomaras;Guido Ferrari;Xiaoying Shen;S. Munir Alam

  • Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

    Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan

  • Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C

    James M. Binley;Elizabeth A. Lybarger;Emma T. Crooks;Michael S. Seaman

  • Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers.

    Olivier Lambotte;Guido Ferrari;Christiane Moog;Nicole L Yates

  • CD4 T follicular helper cell dynamics during SIV infection

    Constantinos Petrovas;Takuya Yamamoto;Michael Y. Gerner;Kristin L. Boswell

  • CXCL13 is a plasma biomarker of germinal center activity

    Colin Havenar-Daughton;Madelene Lindqvist;Antje Heit;Jennifer E. Wu

  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh

  • An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum

    Guido Ferrari;Justin Pollara;Daniel Kozink;Tiara Harms

  • Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.

    Kathryn M. Hastie;Haoyang Li;Daniel Bedinger;Sharon L. Schendel

  • Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection

    Susan Zolla-Pazner;Allan DeCamp;Peter B. Gilbert;Constance Williams

  • COMPASS identifies T-cell subsets correlated with clinical outcomes

    Lin Lin;Greg Finak;Kevin Ushey;Chetan Seshadri

Frequent Co-Authors

David C. Montefiori
David C. Montefiori Duke University
Barton F. Haynes
Barton F. Haynes Duke University
Guido Ferrari
Guido Ferrari Duke University
Hua-Xin Liao
Hua-Xin Liao Duke University
M. Juliana McElrath
M. Juliana McElrath University of Washington
M. Anthony Moody
M. Anthony Moody Duke University
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
S. Munir Alam
S. Munir Alam Duke University
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Robert Parks
Robert Parks Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees online can open diverse career pathways. Many students transition into nursing roles, which complement immunological knowledge and offer hands-on patient care experience. Programs like accelerated nurse practitioner programs provide a fast track for those with prior degrees who want to enter advanced clinical roles swiftly.

Non-nurses exploring a career change might consider online RN programs for non nurses, designed to bridge the gap without traditional nursing backgrounds. These programs boast flexible structures to fit diverse educational histories, making them an accessible entry point.

For quicker entry into the nursing profession, options like the easiest accelerated nursing programs to get into can be appealing. These programs often have more flexible admission criteria while maintaining essential curriculum standards.

Similarly, individuals aiming for licensed practical nurse roles can explore LPN programs with easiest admission requirements, which offer a quicker, more accessible pathway into the nursing field. Combining these degrees with immunology expertise can enhance career flexibility and opportunities in healthcare settings.

Best Scientists Citing Georgia D. Tomaras

Trending Scientists